Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Sep;63(743):735–740. doi: 10.1136/pgmj.63.743.735

The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

M G Harrington 1, P G Kennedy 1
PMCID: PMC2428544  PMID: 3328189

Abstract

The clinical diagnosis of definite multiple sclerosis is supported by abnormalities in the cerebrospinal fluid: variable mild pleocytosis and elevation of total protein, moderately elevated total IgG in most patients, and the almost invariable presence of discrete immunoglobulins after electrophoresis, the oligoclonal bands. The oligoclonal bands are non-specific, and are seen in most diseases of the nervous system, but their temporal uniformity in each patient with multiple sclerosis is characteristic. Prognostically, patients with a single episode of optic neuritis or paraesthesia who have oligoclonal bands are more likely to develop multiple sclerosis than if the spinal fluid were normal. In the Guillain-Barré syndrome, the spinal fluid total protein is transiently elevated, with no pleocytosis. Oligoclonal bands are usually found in the acute phase and only persist in those patients with chronic or relapsing polyneuropathy.

Full text

PDF
735

Images in this article

737Figure 1
on p.737

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Catz I., Warren K. G. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis. Can J Neurol Sci. 1986 Feb;13(1):21–24. doi: 10.1017/s0317167100035745. [DOI] [PubMed] [Google Scholar]
  2. Chu A. B., Sever J. L., Madden D. L., Iivanainen M., Leon M., Wallen W., Brooks B. R., Lee Y. J., Houff S. Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol. 1983 Apr;13(4):434–439. doi: 10.1002/ana.410130410. [DOI] [PubMed] [Google Scholar]
  3. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol. 1978 Jun;3(6):565–566. doi: 10.1002/ana.410030628. [DOI] [PubMed] [Google Scholar]
  4. Dalakas M. C., Papadopoulos N. M. Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies. Ann Neurol. 1984 Jun;15(6):590–593. doi: 10.1002/ana.410150612. [DOI] [PubMed] [Google Scholar]
  5. Duquette P., Charest L. Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology. 1986 May;36(5):727–729. doi: 10.1212/wnl.36.5.727. [DOI] [PubMed] [Google Scholar]
  6. Ersmark B., Sidén A. Isoelectric focusing of CSF proteins and the future evolution of multiple sclerosis: a clinical follow-up. J Neurol. 1984;231(3):117–121. doi: 10.1007/BF00313677. [DOI] [PubMed] [Google Scholar]
  7. Farrell M. A., Kaufmann J. C., Gilbert J. J., Noseworthy J. H., Armstrong H. A., Ebers G. C. Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology. 1985 Feb;35(2):212–218. doi: 10.1212/wnl.35.2.212. [DOI] [PubMed] [Google Scholar]
  8. Fujinami R. S., Oldstone M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043–1045. doi: 10.1126/science.2414848. [DOI] [PubMed] [Google Scholar]
  9. Goldman D., Merril C. R., Ebert M. H. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. Clin Chem. 1980 Aug;26(9):1317–1322. [PubMed] [Google Scholar]
  10. Harrington M. G., Merril C. R., Asher D. M., Gajdusek D. C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 1986 Jul 31;315(5):279–283. doi: 10.1056/NEJM198607313150502. [DOI] [PubMed] [Google Scholar]
  11. Jahnke U., Fischer E. H., Alvord E. C., Jr Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science. 1985 Jul 19;229(4710):282–284. doi: 10.1126/science.2409602. [DOI] [PubMed] [Google Scholar]
  12. Koprowski H., DeFreitas E. C., Harper M. E., Sandberg-Wollheim M., Sheremata W. A., Robert-Guroff M., Saxinger C. W., Feinberg M. B., Wong-Staal F., Gallo R. C. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature. 1985 Nov 14;318(6042):154–160. doi: 10.1038/318154a0. [DOI] [PubMed] [Google Scholar]
  13. Kostulas V. K., Henriksson A., Link H. Monosymptomatic sensory symptoms and cerebrospinal fluid immunoglobulin levels in relation to multiple sclerosis. Arch Neurol. 1986 May;43(5):447–451. doi: 10.1001/archneur.1986.00520050027016. [DOI] [PubMed] [Google Scholar]
  14. Kurtzke J. F. Epidemiologic contributions to multiple sclerosis: an overview. Neurology. 1980 Jul;30(7 Pt 2):61–79. doi: 10.1212/wnl.30.7_part_2.61. [DOI] [PubMed] [Google Scholar]
  15. Lefvert A. K., Link H. IgG production within the central nervous system: a critical review of proposed formulae. Ann Neurol. 1985 Jan;17(1):13–20. doi: 10.1002/ana.410170105. [DOI] [PubMed] [Google Scholar]
  16. McLeod J. G., Walsh J. C., Prineas J. W., Pollard J. D. Acute idiopathic polyneuritis. A clinical and electrophsiological follow-up study. J Neurol Sci. 1976 Feb;27(2):145–162. doi: 10.1016/0022-510x(76)90057-5. [DOI] [PubMed] [Google Scholar]
  17. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. doi: 10.1093/brain/106.4.809. [DOI] [PubMed] [Google Scholar]
  18. Nikoskelainen E., Frey H., Salmi A. Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies. Ann Neurol. 1981 Jun;9(6):545–550. doi: 10.1002/ana.410090606. [DOI] [PubMed] [Google Scholar]
  19. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol. 1978;24:1–39. [PubMed] [Google Scholar]
  20. Panitch H. S., Francis G. S., Hooper C. J., Merigan T. C., Johnson K. P. Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon. Ann Neurol. 1985 Oct;18(4):434–438. doi: 10.1002/ana.410180404. [DOI] [PubMed] [Google Scholar]
  21. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  22. Rudick R. A., Schiffer R. B., Schwetz K. M., Herndon R. M. Multiple sclerosis. The problem of incorrect diagnosis. Arch Neurol. 1986 Jun;43(6):578–583. doi: 10.1001/archneur.1986.00520060042015. [DOI] [PubMed] [Google Scholar]
  23. Sandberg-Wollheim M. Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol Scand. 1975 Sep;52(3):167–178. doi: 10.1111/j.1600-0404.1975.tb05771.x. [DOI] [PubMed] [Google Scholar]
  24. Segurado O. G., Krüger H., Mertens H. G. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. J Neurol. 1986 Aug;233(4):202–208. doi: 10.1007/BF00314019. [DOI] [PubMed] [Google Scholar]
  25. Stendahl-Brodin L., Link H. Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand. 1983 May;67(5):301–304. doi: 10.1111/j.1600-0404.1983.tb04579.x. [DOI] [PubMed] [Google Scholar]
  26. Thompson A. J., Hutchinson M., Martin E. A., Mansfield M., Whelan A., Feighery C. Suspected and clinically definite multiple sclerosis: the relationship between CSF immunoglobulins and clinical course. J Neurol Neurosurg Psychiatry. 1985 Oct;48(10):989–994. doi: 10.1136/jnnp.48.10.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tourtellotte W. On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci. 1970 Mar;10(3):279–304. doi: 10.1016/0022-510x(70)90156-5. [DOI] [PubMed] [Google Scholar]
  28. Vakaet A., Thompson E. J. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry. 1985 Oct;48(10):995–998. doi: 10.1136/jnnp.48.10.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Walsh M. J., Tourtellotte W. W. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med. 1986 Jan 1;163(1):41–53. doi: 10.1084/jem.163.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Whitaker J. N. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology. 1977 Oct;27(10):911–920. doi: 10.1212/wnl.27.10.911. [DOI] [PubMed] [Google Scholar]
  31. Whitaker J. N. Quantitation of the synthesis of immunoglobulin G within the central nervous system. Ann Neurol. 1985 Jan;17(1):11–12. doi: 10.1002/ana.410170104. [DOI] [PubMed] [Google Scholar]
  32. Wiederkehr F., Ogilvie A., Vonderschmitt D. J. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins from patients with various neurological diseases. Clin Chem. 1985 Sep;31(9):1537–1542. [PubMed] [Google Scholar]
  33. Xu X. H., McFarlin D. E. Oligoclonal bands in CSF: twins with MS. Neurology. 1984 Jun;34(6):769–774. doi: 10.1212/wnl.34.6.769. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES